HIGHLIGHTS
- who: Guillain-u00adBarru00e9 syndrome following et al. from the (UNIVERSITY) have published the research work: Guillain-Barreu0301 syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study, in the Journal: (JOURNAL) of 30/06/2021
- what: A previous study found this approach had a high positive predictive value for an incident episode of GBS .
- how: The authors compared age distribution of cases with that of prepandemic GBS cases and clinical features with the International GBS Outcome Study (IGOS). received 67 reports of GBS the ChAdOx1 vaccine (65 first doses) and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.